GFAP and Alzheimer disease: In AD, PD, ALS, FTD, MS as well as prion disease, astrocytes harbor increased expression of GFAP and C3, which are thought to be important (albeit not exclusive) markers of astrocyte reactivity encompassing a neurotoxic phenotype [3,37,60,78,86].